Pixyl

La Tronche, France  All France companies → — Founded 2015
Imaging AI Specialist Specialty-Focused AI
Acquired (by Gleamer on March 3, 2025)

Products

Pixyl.Neuro
Pixyl
Clinical Decision Support & Reference
Pixyl.Neuro is an FDA-cleared AI tool that detects and monitors brain anomalies and changes on MR images for neuroinflammatory and neurodegenerative disorders.

See all 1 product →

About Pixyl

Pixyl is a French healthcare AI company that specializes in neuroimaging analysis, aiming to improve patient care by providing advanced AI technology to radiologists and clinicians. The company’s flagship product, Pixyl.Neuro, is an AI-powered software designed for the automated analysis of brain MRI images. This tool assists in the rapid detection, early diagnosis, and objective monitoring of various neurological disorders, including neuroinflammatory diseases like multiple sclerosis, migraines, and epilepsy, as well as neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and Huntington’s.

Pixyl.Neuro integrates seamlessly into routine radiology workflows, offering features such as automatic detection, quantification, and characterization of lesions, as well as longitudinal analysis to track disease evolution. The software quantifies brain region volumes and compares them to normative data to identify abnormal atrophy, aiding in differential diagnosis. It delivers results within minutes using minimal MRI protocols, thereby enhancing detection rates, accelerating MRI reading times, and providing quantitative information for faster and more confident reporting. Pixyl.Neuro has received CE-mark class IIa certification in the European Union and FDA 510(k) clearance in the United States, underscoring its adherence to high-quality medical device standards.

Focus Areas

AI-powered MRI analysis neuroimaging neurological disorders multiple sclerosis dementia stroke traumatic brain injury precision medicine diagnostic support predictive imaging solutions

Business Intelligence

TechnologyDeep Learning, generative AI technology, cloud-native (Software-as-a-Service - SaaS)

What Physicians Need to Know

AI-Powered MRI Analysis for Neurological Disorders
Pixyl specializes in AI-powered MRI analysis, particularly for neuroinflammatory and neurodegenerative disorders such as Multiple Sclerosis, dementia, stroke, and traumatic brain injury. Their flagship product, Pixyl.Neuro, automatically analyzes brain MRI images to support rapid detection, early diagnosis, and objective monitoring of these conditions.
Enhanced Detection and Accelerated Reading Time
Pixyl.Neuro has demonstrated enhanced detection rates for neurological disease activity, with studies showing up to a 28% improvement. The software is designed to accelerate MRI reading time, providing quick analysis in less than 5 minutes.
Quantitative Biomarkers and Longitudinal Follow-up
The platform provides quantitative measures of lesion volume, brain atrophy, and white matter hyperintensities. It also offers longitudinal analysis, tracking changes over time to monitor disease evolution and treatment response, and comparing patient values to normative data.
Regulatory Clearances and Real-World Validation
Pixyl.Neuro has received FDA 510(k) clearance in the U.S. and CE-mark class IIa certification in the European Union, ensuring high quality in medical device development. The AI-powered technology has been rigorously tested in real-world conditions and clinical studies.
Precision Medicine and Diagnostic Support
Pixyl aims to make precision medicine the standard of care by providing clinicians with access to previously unavailable, clinically relevant information to reinforce radiology workflows and support differential diagnosis.
Physician Tip

For physicians, Pixyl.Neuro can be a game-changer in neurological practice. It offers rapid, objective, and quantitative analysis of brain MRIs, which is crucial for early diagnosis, monitoring disease progression, and tailoring treatment for conditions like Multiple Sclerosis and Alzheimer's disease. The software integrates seamlessly into existing radiology workflows, reducing reading time and providing peace of mind, especially for stable MS MRI exams. The ability to track subtle changes and compare against normative data can significantly enhance diagnostic confidence and patient management.

Pixyl's solutions are designed to integrate seamlessly into the radiology workflow. They are available directly from Pixyl and through select distributors. Pixyl has also formed partnerships with leading healthcare organizations and companies like Gleamer and Brainomix to expand its offerings and distribution.

Products by Pixyl

1 product in the directory

Pixyl.Neuro
Pixyl
Clinical Decision Support & Reference
Pixyl.Neuro is an FDA-cleared AI tool that detects and monitors brain anomalies and changes on MR images for neuroinflammatory and neurodegenerative disorders.

What the Web Says

Pixyl (pixylmedical.com) is a French medtech company that has developed AI-powered software, Pixyl.Neuro, for brain MRI analysis. The software aims to enhance the detection of neurological disease activity, speed up MRI reading time, and support the diagnosis and management of neurodegenerative and neuroinflammatory disorders. It has received FDA 510(k) clearance in the US and CE-mark class IIa certification in the European Union, and is used in over 12 countries. While there are many positive reviews for other companies with similar names (Pixyle AI, Pixly, Pixlr, Pixl, Pixyls crafting kits), specific reviews for Pixyl Medical from the requested sources are limited.

Overall: Positive

Strengths

  • AI-powered software for rapid and objective brain MRI analysis.
  • Enhances detection rates of neurological disease activity.
  • Speeds up MRI reading time and improves radiology workflow.
  • Supports early diagnosis and objective monitoring of neurodegenerative and neuroinflammatory disorders.
  • FDA 510(k) clearance in the US and CE-mark class IIa certification in the EU.
  • Used in over 12 countries across Europe, North America, and Africa.

Limitations

  • Limited specific product or employer reviews available for Pixyl (pixylmedical.com) on G2, Glassdoor, Capterra, or Reddit.
  • Potential confusion with other companies named Pixyl, Pixly, Pixlr, or Pixel, which offer different products and services (e.g., AI for e-commerce, digital signage, photo editing, crafting kits, marketing agency).

Based on reviews from: NeurologyLive, Wiley Analytical Science, Health Tech World, Medical Device Network, Applied Radiology

Last updated: 2026-09-21

Videos

News, demos, and interviews about Pixyl.

Loading videos...

Videos load interactively. If none appear, search YouTube for Pixyl →

View all on YouTube

Press & Coverage

Imaging Technology News
Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro
Pixyl announced FDA 510(k) clearance for Pixyl.Neuro, its next-generation AI software for brain MRI analysis, which has shown enhanced detection rates up to 28%. The software automatically analyzes brain MRI images to support rapid detection, early diagnosis, and objective monitoring of neurological disorders.
2023-12
Applied Radiology
Pixyl Nets FDA Clearance for AI-Powered Brain MR Software | Applied Radiology
Pixyl received FDA 510(k) clearance for its Pixyl.Neuro AI software, which analyzes brain MR images to aid in the detection, diagnosis, and monitoring of neurological disorders. The software also holds CE-mark class IIa certification in the European Union.
2023-11
NeurologyLive
FDA Clears AI-Powered Brain MRI Software Pixyl.Neuro | NeurologyLive
Pixyl.Neuro, an AI-powered medical technology, has received FDA 510(k) clearance for detecting anomalies and changes in brain MR images for neuroinflammatory and neurodegenerative disorders. The software has been used in over 12 countries and provides quick analysis in under 5 minutes.
2023-11
Wiley Analytical Science
AI-powered brain MRI software - 2023 - Wiley Analytical Science
Pixyl's FDA 510(k) clearance for Pixyl.Neuro is a significant step in improving the diagnosis and management of neurodegenerative and neuroinflammatory disorders. The software leverages AI to provide rapid access to crucial information for early disease diagnosis and management.
2023-11
Pixyl (Press Release)
Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro
Pixyl announced FDA 510(k) clearance for Pixyl.Neuro, an AI software for brain MRI analysis that has demonstrated enhanced detection rates. This French medtech company specializes in AI-powered MRI solutions to improve patient care.
2023-11
Multiple Sclerosis News Today
FDA clears AI tool for detecting disease activity on MRI scans - Multiple Sclerosis News
Pixyl.Neuro, an AI-powered software for analyzing MRI scans to detect and monitor multiple sclerosis (MS) disease activity, has received 510(k) clearance from the U.S. FDA. The software aims to improve diagnosis, management, and longitudinal follow-up of neurodegenerative and neuroinflammatory disorders.
2023-11
ActuIA
Pixyl raises u20ac2.2 million to market its neurological pathology detection solution - ActuIA
Pixyl, a French medical imaging company, raised u20ac2.2 million in funding to accelerate the marketing of its Pixyl.Neuro software suite and expand into the US market. The software uses machine learning to identify damaged areas on MRI results for various neurological pathologies.
2021-04
ResearchGate
Use of PIXYL software analysis of brain MRI (with & without contrast) as valuable metric in clinical trial tracking in study of multiple sclerosis (MS) and related neurodegenerative processes
This peer-reviewed article discusses the use of PIXYL software for analyzing brain MRI scans as a valuable metric in clinical trials for multiple sclerosis and other neurodegenerative processes. The software is designed to consistently extract maximum information from MRI brain scans to locate, identify, and quantify lesion changes.
2019-01

Frequently Asked Questions

Pixyl's AI-powered MRI analysis is designed to assist in the diagnosis and monitoring of a range of neurological disorders, including multiple sclerosis, dementia, stroke, and traumatic brain injury. The technology provides quantitative insights from neuroimaging data to support clinicians in their assessment of these complex conditions.
Pixyl's solutions are built for seamless integration into existing clinical workflows, including Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems. This ensures that the AI-powered analysis can be easily incorporated into a physician's current diagnostic process and patient management.
Pixyl's software adheres to stringent regulatory clearances and compliance standards for medical device use, including CE marking under the Medical Device Regulation (MDR) in Europe and FDA clearance in the United States. This ensures the safety, efficacy, and quality of their AI-powered neuroimaging analysis tools.
Yes, Pixyl's AI-powered platform aims to provide predictive imaging solutions that can offer insights into disease progression and potential treatment response for various neurological conditions. By analyzing subtle changes in neuroimaging data over time, the technology supports more personalized and precise patient management.
While specific pricing models can vary based on the scale of implementation and specific modules required, Pixyl generally offers subscription-based models. These typically include comprehensive technical support, regular software updates, and dedicated customer service to ensure optimal performance and user satisfaction.
Pixyl prioritizes the data privacy and security of patient MRI scans by implementing robust encryption protocols and adhering to international data protection regulations such as GDPR and HIPAA. Their systems are designed to process anonymized or de-identified data where appropriate, ensuring patient confidentiality.
Pixyl has established a strong track record in the field of AI neuroimaging, with its technology being adopted by numerous hospitals and research institutions globally. The company continues to expand its market presence through strategic partnerships and ongoing innovation in neurological diagnostic support.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.